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2005, she had increasing shortness of breath with intermittent chest
pain, which led to rehospitalization for clinical assessment and
treatment for heart failure. Echocardiographic study showed LVEDD
62 mm, LVEF 45%, and grade 3 aortic regurgitation of the ISPB.
Blood chemistry studies showed no abnormalities. After successful
treatment for heart failure and exclusion of coronary artery disease
by coronary angiography, she underwent replacement of the ISPB
with a 23-mm Hancock porcine bioprosthesis (Medtronic, Inc,
Minneapolis, Minn) on April 25, 2005. The explanted ISPB
showed dystrophic changes in all 3 cusps (Figures 1 and 2). The
postoperative course was uneventful. The LV function had recov-
ered after 3 months (ejection fraction 55%, LVEDD 55 mm).
Clinically, she was in good cardiovascular condition (New York
Heart Association functional class II) both at an outpatient visit in
August 2005 and at a telephone interview on January 17, 2006.
Comments
This single case report demonstrates that there is potential in the
overall performance of the new-generation pericardial bioprosthe-
ses, particularly in relation to structural valve deterioration in
selected patients younger than 70 years of age.
We have learned from this single case that pericardial biopros-
thesis in general can be implanted in a 50-year-old patient with
comorbidities. Infective endocarditis of a pericardial prosthetic
valve is a relatively uncommon complication occurring in 0.2%/
patient-year,1 and its late occurrence is less common. Acceleration
of structural deterioration of the pericardial tissue valve resulted in
valve incompetence and compromised the LV function in this
patient.
The low-profile ISPB demonstrated excellent hemodynamic
performance and had preserved the LV function for more than 22
years. Finally, this case also supports the fact that new-generation
pericardial bioprostheses may show the same long-term durability
in patients younger than 70 years of age with comorbidities, as was
demonstrated in our 17-year clinical study,1 as well as in other
publications.2
We thank Professor Hans Borst for his contribution and Anne
Gale for editorial assistance.
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The incidence and natural history of papillary musclerupture occurring after chord-sparing mitral valve re-placement for ischemic mitral insufficiency are un-known. A case in which this complication occurred
after chord-sparing mitral valve replacement is described.
Clinical Summary
A 59-year-old man was admitted to our institution with acute heart
failure symptoms and chest discomfort lasting for 3 days. The
electrocardiogram showed sinus tachycardia (115 beats/min) and
pathologic Q waves in the II, III, and aVF leads. The serum
concentrations of creatine kinase MB and troponin I were signif-
icantly elevated. A chest radiograph revealed pulmonary edema.
Two-dimensional transthoracic echocardiography showed akinesia
of inferior and posterior walls and severe mitral regurgitation
caused by posterior leaflet restriction (vena contracta 7 mm).
Coronary angiography showed occluded right and circumflex cor-
onary arteries and a critically narrowed left anterior descending
coronary artery.
On the basis of these findings, mitral valve surgery and coro-
nary artery bypass grafting were recommended. Treatment with
intra-aortic balloon pump support was started, without significant
improvement. Emergency cardiosurgery was performed because of
the patient’s unstable condition. The mitral valve was replaced
with a 29-mm Medtronic Advantage prosthesis (Medtronic, Inc,
Minneapolis, Minn) placed in antianatomic position with preser-
vation of the posterior leaflet (ring annuloplasty was not success-
ful). Coronary artery revascularization was done in the same
operation.
The early postoperative course was uneventful. At the end of
the second week of hospitalization, hypotension and pulmonary
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edema occurred, associated with a decrease in the loudness of
prosthetic valve sounds. Transesophageal echocardiography re-
vealed that one of the prosthetic disks did not move during the
cardiac cycle and stayed in a semiopen position (Figure 1), leading
to severe regurgitation. There was no echocardiographic evidence of
prosthetic valve thrombosis, but additional echo was seen close to the
entrapped disk (Figure 1). Reoperation revealed that the head of the
anteroseptal papillary muscle attached to its chordae tendineae had
ruptured and wedged between one of the disks and prosthetic valve
ring, resulting in the jamming of the disk in a semiopen position
(Figure 2). The mitral valve Medtronic Advantage bileaflet pros-
thesis was replaced with a 27-mm On-X valve prosthesis (Medical
Carbon Research Institute, LLC, Austin, Tex). This time, the
posterior leaflet and subvalvular apparatus were surgically re-
moved. The postoperative course was complicated by ischemic
stroke.
Discussion
Papillary muscle rupture is a complication that occurs in a minority
of cases of acute myocardial infarction.1 The questions raised by
this case concern the incidence of postoperative papillary muscle
rupture after chord-sparing mitral valve replacement for ischemic
mitral regurgitation, as well as the consequences of a flail papillary
muscle segment in the left ventricle, especially its interference
with the prosthetic valve function. There have been reports of
valve prosthetic disk entrapment by surgically divided chordal
remnants, overhanging knots, long suture ends, and atrial cathe-
ters.2 Spontaneous rupture of papillary muscle with entrapment of
the tilting disk of a Medtronic Hall prosthesis has been reported
only twice, in both cases causing death.3,4 Lemke and colleagues5
described a case of spontaneous rupture of papillary muscle after
mitral valve replacement, with normal function of mitral prosthesis
and floating ruptured papillary muscle prolapsing through the
normal aortic valve.
To our knowledge, there are no reports on disk entrapment of
the bileaflet mechanical mitral valve prosthesis caused by sponta-
neous papillary muscle rupture with preserved chordae tendineae.
The case reported here is unusual in that the one of the disks of a
bileaflet prosthetic valve was jammed in a semiopen position while
the other disk function remained normal. It is common knowledge
that preservation of the subvalvular structures—the continuity of
the mitral annulus, chordae tendineae, and papillary muscles—
during mitral valve replacement is important in maximizing ven-
tricular function and maintaining normal ventricular geometry.
Mok and associates4 described hemorrhagic necrosis of the papil-
lary muscle, possibly related to subendocardial ischemia, as the
cause of rupture in 1 case after mitral valve replacement. It is likely
in our case that rupture of the head of papillary muscle was due to
stress on the ischemic papillary muscle by increased tension re-
lated to preservation of the chordae tendineae when the posterior
leaflet was oversewn into the base of the prosthetic mitral valve.
There is also the possibility that the change in the left ventricular
geometry after the operation may have led to increased stress on
the chordae tendineae. For those reasons, every effort should be
made to avoid excessive tension on the papillary muscle whenever
chordal preservation is done, particulary when the papillary muscle
could be ischemic. In view of the current widespread use of
chord-preserving techniques in ischemic mitral valve replacement,
the problem presented in this report is likely to be encountered
again in the future.
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Figure 2. Head of papillary muscle (arrow) wedged between disk
and prosthetic valve ring.
Figure 1. Transesophageal echo-
cardiography shows one normal
prosthetic valve disk motion (long
arrow) and one immobilized
(short arrow) with close addi-
tional echo (arrowhead). A,
Shows 63° view in systole. B,
Shows 63° view in diastole.
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Chondromyxoid fibroma (CMF) was described by Jaffeand Lichtenstein1 in 1948 and is thought to be a rarebenign bone tumor, representing less than 1% of thetotal number of primary bone tumors.2 It predomi-
nantly affects the long bones and rarely occurs in the sternum. In
this communication we report a case of CMF of the sternum with
a brief review of the literature.
Clinical Summary
The patient was a 17-year-old man whose chief complaint was
pain in the anterior part of the chest. He had occasionally experi-
enced anterior chest pain since about August 2000 and had con-
sulted a local physician because the pain was aggravated by a fall
in June 2002. A plain x-ray examination had revealed a bone tumor
in the sternum. The patient was first referred to us in July 2002,
and he was admitted for surgery in September 2002. During the
initial physical examination, a tender swelling that was mildly
warm to palpation was found in the middle of the lower sternum.
A plain x-ray film showed an eccentrically located multilobular
radiolucency with mild calcification in the lower sternum. Com-
puted tomography revealed an osteolytic lesion with discrete cal-
cification in the bone marrow of the sternum (Figure 1, A). The
lesion was visualized as an isointense area by T1-weighted mag-
netic resonance imaging and as a well-marginated high-intensity
area by T2-weighted magnetic resonance imaging with a slightly
lobular pattern (Figure 1, B). On the gadolinium-enhanced T1-
weighted image the tumor was well enhanced. On the basis of
these findings, a malignant cartilaginous tumor of the sternum was
suspected, and a biopsy of the lesion was obtained.
Histologic examination of the biopsy specimen revealed a
slightly lobular architecture composed of myxoid matrix populated
by stellate or elongate cells with eosinophilic cytoplasmic pro-
cesses. These myxoid areas were interspersed in a background of
more cellular regions containing dilated sinusoidal vessels and
focal hemorrhage. These findings were compatible with CMF
because there were practically no mitotic figures and the cellular
atypia was minimal (Figure 2, A and B). On the basis of these
histologic findings, the following surgical procedure was per-
formed. A part of the cortex was removed from the anterior surface
of the sternum. The lesion in the bone marrow was completely
curetted, and the remaining lesion was ground off with an air drill.
The space after curettage was completely filled with bone allograft
fragments. The histologic diagnosis of the surgical specimen was
CMF as suspected from the biopsy. The patient’s clinical course
has been uneventful with no local recurrence thus far, 3 years
6 months postoperatively.
Discussion
CMF is the least common benign cartilaginous tumor, and only
106 cases were registered in the Japanese Bone Tumor Registry in
the 21 years from 1972 to 1993.3 It accounts for 0.45% of all
primary bone tumors. The most prevalent site is the metaphysis of
long bone, and the affected sites reported have been the tibia in 33
cases (31%), the femur in 23 cases (22%), and the humerus in 9
cases (8.5%). During the above period, 71 cases of sternal primary
bone tumors were reported, including 18 cases of osteochondroma,
15 cases of chondrosarcoma, and 14 cases of chondroma. Among
these tumors, particular caution is required to differentiate chon-
drosarcoma from CMF. Because of the presence of pleomorphic
cells with hyperchromatic nuclei, the histologic diagnosis of CML
may sometimes be difficult and an erroneous diagnosis of chon-
drosarcoma may result.
To the best of our knowledge, there have been no reports of CMF
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